49 Wealth Management’s Beta Bionics BBNX Stock Holding History

49 Wealth Management’s Portfolio BBNX Stock Details BBNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,906	Closed	-$119K	–	307
2026 Q1	$119K	Buy	+11,906	New	+$176K	0.01%	194

Other funds holding BBNX

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

49 Wealth Management's BBNX Position: Q2 2026 in Review

49 Wealth Management sold out of Beta Bionics (BBNX) in Q2 2026, closing a stake of 11,906 shares — an estimated $119K sold.

49 Wealth Management first reported a position in BBNX in Q1 2026 and held it in 1 quarter. The position peaked at $119K in Q1 2026. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

49 Wealth Management reported no remaining Beta Bionics position as of Q2 2026 after selling out during the quarter.
49 Wealth Management sold 11,906 Beta Bionics shares in Q2 2026, an estimated $119K.
49 Wealth Management first reported a position in Beta Bionics in Q1 2026 and held it in 1 quarter.
49 Wealth Management's Beta Bionics position peaked at $119K in Q1 2026.
133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on 49 Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.